CN104341457A - 一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法 - Google Patents

一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法 Download PDF

Info

Publication number
CN104341457A
CN104341457A CN201410568265.1A CN201410568265A CN104341457A CN 104341457 A CN104341457 A CN 104341457A CN 201410568265 A CN201410568265 A CN 201410568265A CN 104341457 A CN104341457 A CN 104341457A
Authority
CN
China
Prior art keywords
functionalization
nickel compound
double
triazole
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410568265.1A
Other languages
English (en)
Other versions
CN104341457B (zh
Inventor
顾绍金
杜杰毫
黄菁菁
徐卫林
夏欢
徐灿红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Textile University
Original Assignee
Wuhan Textile University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Textile University filed Critical Wuhan Textile University
Priority to CN201410568265.1A priority Critical patent/CN104341457B/zh
Publication of CN104341457A publication Critical patent/CN104341457A/zh
Application granted granted Critical
Publication of CN104341457B publication Critical patent/CN104341457B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04Nickel compounds
    • C07F15/045Nickel compounds without a metal-carbon linkage
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2217At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/32Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero-atoms other than or in addition to oxygen or halogen
    • C07C1/325Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero-atoms other than or in addition to oxygen or halogen the hetero-atom being a metal atom
    • C07C1/326Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero-atoms other than or in addition to oxygen or halogen the hetero-atom being a metal atom the hetero-atom being a magnesium atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/127Preparation from compounds containing pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B01J2231/4233Kumada-type, i.e. RY + R'MgZ, in which Ris optionally substituted alkyl, alkenyl, aryl, Y is the leaving group and Z is halide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • C07C2531/22Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

本发明涉及一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法,属于金属有机化学领域。一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物是以1,2,3-三唑功能化的氮杂环卡宾为配体,氮杂环卡宾与镍的摩尔比为1:1,其分子结构式为:其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种;X为PF6或BF4中的一种。1,2,3-三唑功能化氮杂环卡宾双核镍化合物制备方法简单,双核镍卡宾化合物对空气和湿气稳定,镍原子之间距离较短,具有金属-金属间作用,利用该类催化剂,可以高效的实现交叉偶联反应,以高于90%的收率得到多种联苯衍生物,具有很好的官能团兼容性,环境友好,可广泛的应用于精细化工和制药工业中。

Description

一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法
技术领域
本发明涉及一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法,属于金属有机化学技术领域。
背景技术
近几年来,氮杂环卡宾配体由于其独特的电子性能比较膦配体更高的对热和空气的稳定性,已经被作为膦配体的补充和替代,广泛应用于催化各种有机化学反应中,尤其是双金属化合物优越的催化性能,使得其受到了很大的关注(Korbinian Riener,Stefan Haslinger,Andreas Raba,Manuel P.Mirza Cokoja,Wolfgang A.Herrmann,and Fritz E.Kühn,Chemistry of Iron N-HeterocyclicCarbene Complexes:Syntheses,Structures,Reactivities,and Catalytic Applications,Chem.Rev.,2014,114,5215–5272;Diez-Gonzalez,S.,Marion,N.,and Nolan,S.P.N-Heterocyclic Carbenes in Late Transition Metal Catalysis,Chem.Rev.,2009,109,3612-3676)。尽管如此,在已经公开的报道中,氮杂环卡宾支撑的双核镍化合物的研究仍然很少(中国专利CN201110241732,Zhou Y,Xi Z,Chen W,Wang D.,Dinickel(II)Complexes of Bis(N-heterocyclic carbene)Ligands Containing[Ni2(μ-OH)]Cores as Highly Efficient Catalysts for the Coupling of Aryl Chlorides,Organometallics,2008,27,5911-5920;Xi Z,Zhou Y,Chen W.,Efficient NegishiCoupling Reactions of Aryl Chlorides Catalyzed by Binuclear and MononuclearNickel-N-Heterocyclic Carbene Complexes,The Journal of Organic Chemistry,2008,73,8497-8501),然而上述报道的双核镍卡宾化合物仅限于吡唑功能化化合物,1,2,3-三唑功能化氮杂环卡宾双核镍化合物的制备及其在催化交叉偶联反应中的应用还未见报道。双核金属化合物由于金属-金属间的相互作用,能够在催化反应过程中起到协同催化作用,从而显著地提高催化剂的催化活性,因此简单方便地制备对空气和水汽有很好稳定性的氮杂环卡宾双核镍化合物,实现温和条件下,高效的催化交叉偶联反应,在工业上具有广泛的应用前景。
发明内容
针对上述不足,本发明的目的在于提供一种在镍催化的交叉偶联反应中具有高效催化活性的1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法,为实现上述目的,本发明的技术解决方案是:
一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物,所述1,2,3-三唑功能化氮杂环卡宾双核镍化合物的分子结构式I为:
其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种。
X为PF6或BF4中的一种。
将1,2,3-三唑功能化氮杂环卡宾配体和氧化银以2:1的摩尔比加入到盛有1,2,3-三唑功能化氮杂环卡宾配体质量50倍乙腈的Schlenk反应管内,其中所述1,2,3-三唑功能化氮杂环卡宾配体的分子结构式II为:
其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种;X为PF6或BF4中的一种;空气氛围中,50℃下,避光搅拌反应10-15小时;随后,加入与1,2,3-三唑功能化氮杂环卡宾配体摩尔比为1:1的NiCl2(PPh3)2,在25℃下搅拌反应5-10小时;离心过滤掉沉淀物,浓缩滤液,加入浓缩液10倍体积的无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为I
的1,2,3-三唑功能化氮杂环卡宾双核镍化合物。
其中,R1为咪唑或苯并咪唑,
R2为苄基或正丁基或苯基中的一种,
X为PF6或BF4中的一种。
由于采用以上技术方案,本发明具有以下优点:
氮杂环卡宾给电子能力强、易于制备、易官能化而且环境友好等特点成为金属有机化学领域的研究热点,氮杂环卡宾过渡金属化合物在均相催化领域已经取得了很大地成功,而1,2,3-三唑作为常见的杂环化合物配体,在金属化合物中可以作为辅助配体参与络合,同时1,2,3-三唑功能化的氮杂环卡宾前体可以方便的通过铜催化的点击反应制备,相对于吡唑桥连的双金属卡宾镍化合物,和已有的技术方法相比,反应步骤简单,得到化合物的结构新颖,产率高,适合于大规模制备。本发明结合1,2,3-三唑弱配位的特点以及氮杂环卡宾的优点通过铜催化的点击反应制备了1,2,3-三唑功能化的氮杂环卡宾配体,并经过简单的银卡宾金属交换反应制备了1,2,3-三唑功能化氮杂环卡宾双核镍化合物。在双核镍化合物中,由于1,2,3-三唑的特殊的电子性能,得到了每个镍原子同时和一个吡啶氮原子、一个1,2,3-三唑氮原子、一个卡宾碳原子配位,并与另外的镍原子通过羟基桥连形成了双核镍卡宾化合物。
利用1,2,3-三唑功能化氮杂环卡宾双核镍为催化剂,25℃下,可以使取代氯苯衍生物与溴苯格氏试剂反应形成联苯衍生物,可用下式表示:
其中,R3为氢原子或吡啶基或甲基或甲氧基,R4为甲基或甲氧基。
溴苯格氏试剂衍生物与氯苯衍生物的摩尔比为1.2:1,1,2,3-三唑功能化氮杂环卡宾双核镍化合物相对于氯苯衍生物的用量为0.5mol%,反应的时间为3~12小时。
利用1,2,3-三唑功能化氮杂环卡宾双核镍为催化剂,80℃下,可以使取代氯苯衍生物与取代苯硼酸反应形成联苯衍生物,可用下式表示:
其中,R3为氢原子或吡啶基或甲基或甲氧基,R4为甲基或甲氧基。
取代苯硼酸与氯苯衍生物的摩尔比为1.2:1,1,2,3-三唑功能化氮杂环卡宾双核镍化合物相对于氯苯衍生物的用量为0.2mol%,反应的时间为2~4小时。
双核镍卡宾化合物的制备利用简单方便的金属交换反应得到,无需无水无氧操作,制备方法简单,设备要求低,操作控制方便,产率高,易于实现工业化生产。双核镍卡宾化合物对空气和湿气稳定,由于镍原子之间距离较短,具有金属-金属间作用,利用该类催化剂,可以高效的实现交叉偶联反应,以高于90%的收率得到多种联苯衍生物,具有很好的官能团兼容性,显示出了很好的协同催化作用,催化反应条件温和,催化效率高,环境友好,在精细化工和制药工业中具有广泛的应用前景。
具体实施方式
以下结合具体实施例对本发明做进一步的描述。
一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物,所述1,2,3-三唑功能化氮杂环卡宾双核镍化合物的分子结构式I为:
其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种。
X为PF6或BF4中的一种。
将1,2,3-三唑功能化氮杂环卡宾配体和氧化银以2:1的摩尔比加入到盛有1,2,3-三唑功能化氮杂环卡宾配体质量50倍乙腈的Schlenk反应管内,其中所述1,2,3-三唑功能化氮杂环卡宾配体的分子结构式II为:
其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种;X为PF6或BF4中的一种;空气氛围中,50℃下,避光搅拌反应10-15小时;随后,加入与1,2,3-三唑功能化氮杂环卡宾配体摩尔比为1:1的NiCl2(PPh3)2,在25℃下搅拌反应5-10小时;离心过滤掉沉淀物,浓缩滤液,加入浓缩液10倍体积的无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为I
的1,2,3-三唑功能化氮杂环卡宾双核镍化合物;
其中,R1为咪唑或苯并咪唑,
R2为苄基或正丁基或苯基中的一种。
X为PF6或BF4中的一种。
由于采用了以上技术方案,本发明所使用1,2,3-三唑功能化氮杂环卡宾配体和双金属卡宾镍化合物容易制备,在空气中稳定,和已有的技术方法相比,配体采用铜催化的点击反应在水相中制备得到,制备方法简单,电子和立体性能易于调节,品种多样。相对于吡唑桥连的双金属卡宾镍化合物,和已有的技术方法相比,反应步骤简单,得到化合物的结构新颖,产率高,适合于大规模制备。本发明结合1,2,3-三唑弱配位的特点以及氮杂环卡宾的优点通过铜催化的点击反应制备了1,2,3-三唑功能化的氮杂环卡宾配体,并经过简单的银卡宾金属交换反应制备了1,2,3-三唑功能化氮杂环卡宾双核镍化合物。在双核镍化合物中,由于1,2,3-三唑配体特殊的电子和空间性能,得到了每个镍原子同时和一个吡啶氮原子、一个1,2,3-三唑氮原子、一个卡宾碳原子配位,并与另外的镍原子通过羟基桥连形成了双核镍卡宾化合物。制备本发明化合物的起始物质正丁基叠氮、苯基叠氮、苄基叠氮、2-氯甲基吡啶、3-溴丙炔,咪唑、苯并咪唑等均可以从市场上买到或容易地通过已知的方法制得,所有用于合成和分析的试剂都是分析纯,并没有经过进一步的处理。
具体实施例
实施例1
50℃下,在Schlenk反应管内加入1,2,3-三唑功能化氮杂环卡宾配体L1(477mg,1mmol),氧化银(116mg,0.5mmol)和乙腈20mL,反应10小时,随后加入NiCl2(PPh3)2(654mg,1mmol),在25℃下搅拌反应6小时,离心过滤掉沉淀物,滤液浓缩至2mL,加入20mL无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为1的1,2,3-三唑功能化氮杂环卡宾双核镍化合物700mg,产率55%。1H NMR(400MHz,d6-DMSO):δ8.54(b,1H),8.30(s,1H),7.89(t,J=7.2Hz,1H),7.79(s,2H),7.48(d,J=7.6Hz,1H),7.39-7.33(m,6H),5.64(s,2H),5.68(s,4H)ppm.13C NMR(400MHz,d6-DMSO):δ156.9(Ni-C),153.9,150.1,141.2,138.0,137.5,136.2,129.3,128.8,125.1,124.2,123.9,123.1,123.0,53.6,53.5,44.2ppm.
利用上述步骤得到的分子结构式为1的1,2,3-三唑功能化氮杂环卡宾双核镍化合物为催化剂,25℃下,以四氢呋喃为溶剂,可使氯苯与对甲基溴苯的格氏试剂形成4-甲基联苯,具体例子为:
在氮气保护下,在Schlenk反应管内加入6.4mg(0.5mol%)双核镍化合物1,氯苯(112mg,1.0mmol),对甲基溴苯的格氏试剂1.2mmol,25℃反应10小时,加入稀盐酸溶液10mL,后加入乙酸乙酯萃取,有机层用MgSO4干燥,过滤,浓缩,硅胶柱层析分离,得到产物4-甲基联苯,产率:164mg(98%)。1H NMR(400MHz,CDCl3):δ7.58(d,J=8.0Hz,2H),7.51(d,J=8.0Hz,2H),7.44(t,J=7.6Hz,2H),7.32(t,J=7.6Hz,2H),7.24(t,J=7.6Hz,2H),2.38(s,3H)ppm。
实施例2
50℃下,在Schlenk反应管内加入1,2,3-三唑功能化氮杂环卡宾配体L2(527mg,1mmol),氧化银(116mg,0.5mmol)和乙腈20mL,反应15小时,随后加入NiCl2(PPh3)2(654mg,1mmol),在25℃下搅拌反应7小时,离心过滤掉沉淀物,滤液浓缩至2mL,加入20mL无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为2的1,2,3-三唑功能化氮杂环卡宾双核镍化合物714mg,产率52%。1H NMR(400MHz,d6-DMSO):δ8.79(b,1H),8.46-8.44(m,1H),8.39(s,1H),8.29(t,J=8.0Hz,1H),8.18-8.16(m,1H),8.06(d,J=8.0Hz,1H),7.78-7.72(m,3H),7.37-7.30(m,6H),5.98(s,2H),5.68(s,2H),5.63(s,2H)ppm.13C NMR(400MHz,d6-DMSO):δ157.9(Ni-C),153.9,149.9,147.6,143.1,141.1,140.5,136.2,131.7,130.1,129.3,128.8,128.5,128.3,127.7,125.7,125.5,117.7,116.4,114.8,53.6,53.4,42.9ppm.
利用上述步骤得到的分子结构式为2的1,2,3-三唑功能化氮杂环卡宾双核镍化合物为催化剂,25℃下,以四氢呋喃为溶剂,可使对甲氧基氯苯与对甲基溴苯的格氏试剂形成4-甲氧基-4’-甲基联苯,具体例子为:
在氮气保护下,在Schlenk反应管内加入6.4mg(0.5mol%)双核镍化合物1,对氧基氯苯(142mg,1.0mmol),对甲基溴苯的格氏试剂1.2mmol,25℃反应5小时,加入稀盐酸溶液10mL,后加入乙酸乙酯萃取,有机层用MgSO4干燥,过滤,浓缩,硅胶柱层析分离,得到产物4-甲氧基-4’-甲基联苯,产率:188mg(95%)。1H NMR(400MHz,CDCl3):δ7.53(d,J=8.4Hz,2H),7.47(d,J=8.0Hz,2H),7.24(m,2H),6.97(d,J=8.8Hz,2H),3.85(s,3H),2.38(s,3H)ppm。
实施例3
50℃下,在Schlenk反应管内加入1,2,3-三唑功能化氮杂环卡宾配体L3(443mg,1mmol),氧化银(116mg,0.5mmol)和乙腈20mL,反应15小时,随后加入NiCl2(PPh3)2(654mg,1mmol),在25℃下搅拌反应8小时,离心过滤掉沉淀物,滤液浓缩至2mL,加入20mL无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为3的1,2,3-三唑功能化氮杂环卡宾双核镍化合物747mg,产率62%。1H NMR(400MHz,DMSO-d6):δ9.05(s,1H,triazole),8.63(d,1H),8.16-8.14(m,2H),7.87(s,1H),7.82(s,1H),7.61-7.58(m,1H),5.68(s,2H),5.65(s,2H),4.18(t,J=7.8Hz,2H),1.79-1.74(m,2H),1.31-1.24(m,2H),0.90(t,3H,J=7.2Hz,).13C NMR(100MHz,DMSO-d6):δ154.2(Ni-C),149.5,148.7,142.0,136.8,125.1,123.2,123.1,122.5,114.2,53.6,49.2,44.0,31.7,19.2,13.7.
利用上述步骤得到的分子结构式为3的1,2,3-三唑功能化氮杂环卡宾双核镍化合物为催化剂,25℃下,以四氢呋喃为溶剂,可使对2-氯吡啶与对甲基溴苯的格氏试剂形成4-甲基-2’-苯基吡啶,具体例子为:
在氮气保护下,在Schlenk反应管内加入6.1mg(0.5mol%)双核镍化合物3,2-氯吡啶(113mg,1.0mmol),对甲基溴苯的格氏试剂1.2mmol,四氢呋喃2mL,25℃反应5小时,加入稀盐酸溶液10mL,后加入乙酸乙酯萃取,有机层用MgSO4干燥,过滤,浓缩,硅胶柱层析分离,得到产物4-甲基-2’-苯基吡啶,产率:169mg(100%)。1H NMR(400MHz,CDCl3):δ8.68(d,J=4.4Hz,1H),7.91(d,J=8.0Hz,2H),7.68(m,2H),7.29(d,J=8.0Hz,2H),7.16(m,1H),2.38(s,3H)ppm。
实施例4
50℃下,在Schlenk反应管内加入1,2,3-三唑功能化氮杂环卡宾配体L4(384mg,1mmol),氧化银(116mg,0.5mmol)和乙腈20mL,反应12小时,随后加入NiCl2(PPh3)2(654mg,1mmol),在25℃下搅拌反应9小时,离心过滤掉沉淀物,滤液浓缩至2mL,加入20mL无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为4的1,2,3-三唑功能化氮杂环卡宾双核镍化合物588mg,产率57%。1H NMR(400MHz,d6-DMSO):δ8.56(b,1H),8.33(s,1H),7.85(t,J=7.2Hz,1H),7.78(s,2H),7.49(d,J=7.6Hz,1H),7.38-7.32(m,6H),5.65(s,2H),5.66(s,4H)ppm.13C NMR(400MHz,d6-DMSO):δ156.6(Ni-C),153.9,150.1,141.2,138.0,137.5,136.2,129.3,128.8,125.1,124.2,123.9,123.1,123.0,53.6,53.5,44.2ppm.
利用上述步骤得到的分子结构式为4的1,2,3-三唑功能化氮杂环卡宾双核镍化合物为催化剂,80℃下,以甲苯为溶剂,可使对氯甲苯与苯硼酸反应形成4-甲基联苯,具体例子为:
在氮气保护下,在Schlenk反应管内加入2.1mg(0.2mol%)双核镍化合物4,对氯甲苯(126mg,1.0mmol),苯硼酸(145mg,1.2mmol),K3PO4(422mg,2mmol),3mL甲苯,80℃反应3小时,加入水10mL,后加入乙酸乙酯萃取,有机层用MgSO4干燥,过滤,浓缩,硅胶柱层析分离,得到产物4-甲基联苯,产率:164mg(98%)。1H NMR(400MHz,CDCl3):δ7.58(d,J=8.0Hz,2H),7.51(d,J=8.0Hz,2H),7.44(t,J=7.6Hz,2H),7.32(t,J=7.6Hz,2H),7.24(t,J=7.6Hz,2H),2.38(s,3H)ppm。
实施例5
50℃下,在Schlenk反应管内加入1,2,3-三唑功能化氮杂环卡宾配体L5(513mg,1mmol),氧化银(116mg,0.5mmol)和乙腈20mL,反应15小时,随后加入NiCl2(PPh3)2(654mg,1mmol),在25℃下搅拌反应10小时,离心过滤掉沉淀物,滤液浓缩至2mL,加入20mL无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10h,得到分子结构式为5的1,2,3-三唑功能化氮杂环卡宾双核镍化合物713mg,产率53%。1H NMR(400MHz,d6-DMSO):δ9.56(d,J=5.2Hz,1H),9.23(s,1H),8.33(t,J=7.2Hz,1H),8.08-8.04(m,3H),7.91(d,J=7.2Hz,2H),7.76(t,J=6.4Hz,1H),7.71-7.63(m,3H),7.58-7.56(m,2H),6.07(s,2H),5.89(s,2H)ppm.13C NMR(400MHz,d6-DMSO):δ160.5(Ni-C),152.6,141.9,136.9,130.5,129.6,124.4,123.7,122.9,120.7,120.0,124.2,53.6,44.2ppm.
利用上述步骤得到的分子结构式为5的1,2,3-三唑功能化氮杂环卡宾双核镍化合物为催化剂,80℃下,以甲苯为溶剂,可使对氯苯甲醚与苯硼酸形成4-甲氧基联苯,具体例子为:
在氮气保护下,在Schlenk反应管内加入2.6mg(0.2mol%)双核镍化合物5,对氯苯甲醚(142mg,1.0mmol),苯硼酸(145mg,1.2mmol),K3PO4(422mg,2mmol),3mL甲苯,80℃反应5小时,加入水10mL,后加入乙酸乙酯萃取,有机层用MgSO4干燥,过滤,浓缩,硅胶柱层析分离,得到产物4-甲基联苯,产率:164mg(98%)。1H NMR(400MHz,CDCl3):δ7.55(d,J=8.4Hz,2H),7.48(d,J=8.0Hz,2H),7.26(m,2H),6.98(d,J=8.8Hz,2H),3.85(s,3H)ppm。

Claims (2)

1.一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物,其特征在于:所述1,2,3-三唑功能化氮杂环卡宾双核镍化合物的分子结构式I为:
其中R1为咪唑或苯并咪唑,R2为苄基或正丁基或苯基中的一种;
X为PF6或BF4中的一种。
2.一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物的制备方法,其特征在于:将1,2,3-三唑功能化氮杂环卡宾配体和氧化银以2:1的摩尔比加入到盛有1,2,3-三唑功能化氮杂环卡宾配体质量50倍乙腈的Schlenk反应管内,其中所述1,2,3-三唑功能化氮杂环卡宾配体的分子结构式II为:
其中,R1为咪唑或苯并咪唑;
R2为苄基或正丁基或苯基中的一种;
X为PF6或BF4中的一种;
空气氛围中,50℃下,避光搅拌反应10-15小时;随后,加入与1,2,3-三唑功能化氮杂环卡宾配体摩尔比为1:1的NiCl2(PPh3)2,在25℃下搅拌反应5-10小时;离心过滤掉沉淀物,浓缩滤液,加入浓缩液10倍体积的无水乙醚,析出固体,过滤收集固体,30℃下真空干燥10小时,得到分子结构式为I
的1,2,3-三唑功能化氮杂环卡宾双核镍化合物;
其中,R1为咪唑或苯并咪唑;
R2为苄基或正丁基或苯基中的一种;
X为PF6或BF4中的一种。
CN201410568265.1A 2014-10-22 2014-10-22 一种1,2,3‑三唑功能化氮杂环卡宾双核镍化合物及其制备方法 Expired - Fee Related CN104341457B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410568265.1A CN104341457B (zh) 2014-10-22 2014-10-22 一种1,2,3‑三唑功能化氮杂环卡宾双核镍化合物及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410568265.1A CN104341457B (zh) 2014-10-22 2014-10-22 一种1,2,3‑三唑功能化氮杂环卡宾双核镍化合物及其制备方法

Publications (2)

Publication Number Publication Date
CN104341457A true CN104341457A (zh) 2015-02-11
CN104341457B CN104341457B (zh) 2017-03-15

Family

ID=52497980

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410568265.1A Expired - Fee Related CN104341457B (zh) 2014-10-22 2014-10-22 一种1,2,3‑三唑功能化氮杂环卡宾双核镍化合物及其制备方法

Country Status (1)

Country Link
CN (1) CN104341457B (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610378A (zh) * 2015-02-26 2015-05-13 天津师范大学 具有潜在荧光材料的氧醚双三唑镍配合物及其制备方法
CN108456172A (zh) * 2018-04-20 2018-08-28 浙江大学城市学院 一种具有苯并咪唑骨架的手性氮杂环卡宾前体化合物及其制备方法和应用
CN109503311A (zh) * 2018-12-14 2019-03-22 国药集团化学试剂有限公司 一种对三联苯的制备方法
CN110092761A (zh) * 2018-01-31 2019-08-06 中国人民大学 卤代1,2,3-三唑卡宾及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100376324C (zh) * 2002-08-07 2008-03-26 尤米科尔股份公司及两合公司 新颖的镍、钯和铂-碳烯配合物及其制备和在催化反应中的应用
CN101284247A (zh) * 2008-05-23 2008-10-15 浙江大学 氮杂环卡宾配体支撑的双核镍交叉偶联反应催化剂及制备方法
US20090143551A1 (en) * 2007-11-15 2009-06-04 Zengquan Qin Nickel-based catalysts for preparing high cis 1,4-polydienes
CN102351907A (zh) * 2011-08-22 2012-02-15 浙江大学 一种合成金属氮杂环卡宾配合物的方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100376324C (zh) * 2002-08-07 2008-03-26 尤米科尔股份公司及两合公司 新颖的镍、钯和铂-碳烯配合物及其制备和在催化反应中的应用
US20090143551A1 (en) * 2007-11-15 2009-06-04 Zengquan Qin Nickel-based catalysts for preparing high cis 1,4-polydienes
CN101284247A (zh) * 2008-05-23 2008-10-15 浙江大学 氮杂环卡宾配体支撑的双核镍交叉偶联反应催化剂及制备方法
CN102351907A (zh) * 2011-08-22 2012-02-15 浙江大学 一种合成金属氮杂环卡宾配合物的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
顾绍金等,: "三唑官能化N-杂环卡宾镍化合物的合成及催化性能", 《中国化学会·第八届有机化学学术会议暨首届重庆有机化学国际研讨会》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610378A (zh) * 2015-02-26 2015-05-13 天津师范大学 具有潜在荧光材料的氧醚双三唑镍配合物及其制备方法
CN110092761A (zh) * 2018-01-31 2019-08-06 中国人民大学 卤代1,2,3-三唑卡宾及其制备方法和应用
CN108456172A (zh) * 2018-04-20 2018-08-28 浙江大学城市学院 一种具有苯并咪唑骨架的手性氮杂环卡宾前体化合物及其制备方法和应用
CN108456172B (zh) * 2018-04-20 2021-01-12 浙江大学城市学院 一种具有苯并咪唑骨架的手性氮杂环卡宾前体化合物及其制备方法和应用
CN109503311A (zh) * 2018-12-14 2019-03-22 国药集团化学试剂有限公司 一种对三联苯的制备方法

Also Published As

Publication number Publication date
CN104341457B (zh) 2017-03-15

Similar Documents

Publication Publication Date Title
CN102491987B (zh) 一种邻菲啰啉功能化氮杂环卡宾四核铜化合物及其制备方法
US7250510B2 (en) Transition metal complexes of N-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations
CN101402644B (zh) 金属氮杂环卡宾配合物的制备方法
CN104341457A (zh) 一种1,2,3-三唑功能化氮杂环卡宾双核镍化合物及其制备方法
CN102153592A (zh) 氮杂环卡宾-钯-咪唑络合物催化芳基氯化物室温水相铃木偶联反应
Hayasaka et al. Highly efficient olefin hydrosilylation catalyzed by iron complexes with iminobipyridine ligand
Shigeng et al. Synthesis, structure, and catalytic activity of palladium complexes with new chiral cyclohexane-1, 2-based di-NHC-ligands
Rendón-Nava et al. Hydroxyl-functionalized triazolylidene-based PEPPSI complexes: metallacycle formation effect on the Suzuki coupling reaction
CN101284247B (zh) 氮杂环卡宾配体支撑的双核镍交叉偶联反应催化剂及制备方法
Karataş et al. N-heterocyclic carbene palladium complexes with different N-coordinated ligands: Comparison of their catalytic activities in Suzuki-Miyaura and Mizoroki-Heck reactions
CN109694382A (zh) 一种室温下制备芳基硼酸酯的方法
US11236118B1 (en) Selective cyclocarbonylative coupling of 2-iodophenols with terminal alkynes catalyzed by bridged bis(NHC)Pd(II)Br2 catalysts
De la Fuente‐Olvera et al. Synthesis and Catalytic Applications of Palladium (II) Complexes Supported by Hydroxyl‐Functionalized Triazolylidenes
KR20160007581A (ko) 피리딘- 또는 피라진-함유 화합물
CN114907404B (zh) 5-(2-(二取代膦基)苯基)-1-烷基-1h-吡唑膦配体及其制备方法和应用
CN114773614A (zh) 一种双金属可控分布的超分子材料及其制备方法
CN105693696A (zh) 一种氨基吡唑基双吡啶及其制备方法
US10093692B2 (en) Phosphines, synthesis thereof and their use in catalysis
CN110483503B (zh) 具有酰胺远程碱性官能团的咪唑类卡宾配体及其合成方法与应用
CN112694489B (zh) N-杂环卡宾铜催化剂的制备方法
JP6011769B2 (ja) ポリスチレン担持ピリジンビスオキサゾリン誘導体−カルシウム触媒
CN112979513A (zh) 一种含苯乙烯单体的手性亚砜及其制备方法
Zhang et al. Reactions of [FeL 2 (CH 3 CN) 2](PF 6) 2 (L= N-pyrimid-2-ylimidazol-ylidene) with N-, P-, O-, and S-donors and its catalytic activity
JP2016536297A (ja) 芳香族アミンのモノアリール化
KR102066464B1 (ko) 알킨의 헤테로아렌과의 카르보닐화를 위한 마르코브니코프-선택적 팔라듐 촉매

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170315

Termination date: 20181022

CF01 Termination of patent right due to non-payment of annual fee